Literature DB >> 9228136

Cartilage damage as a result of hemarthrosis in a human in vitro model.

G Roosendaal1, M E Vianen, H M van den Berg, F P Lafeber, J W Bijlsma.   

Abstract

OBJECTIVE: To investigate the direct effect of blood and blood components on human cartilage in vitro.
METHODS: Healthy human articular cartilage tissue was obtained post mortem and cultured according to standard procedures. The harmful effects of whole blood and various isolated blood components as well as the reversibility of these effects were assessed by means of proteoglycan synthesis and proteoglycan release.
RESULTS: Whole blood anticoagulated with heparin, coagulated blood, mononuclear cells (MNC), erythrocytes [red blood cells (RBC)] and plasma, in this order of potency, decreased proteoglycan synthesis in a dose dependent manner. The effect of the combination of MNC and RBC in concentrations equivalent to those in whole blood was significantly greater than the effect of each of these isolated components alone and did not differ from that of whole blood. Moreover, cartilage exposed for 4 days to this combination exhibited irreversible inhibition of proteoglycan synthesis. The effect was similar to that of whole blood, the opposite of that of the individual components or other combinations.
CONCLUSION: Results suggest a direct irreversible harmful effect of whole blood on cartilage, whereby MNC and RBC together are the main factors. Taking into account that the concentration of blood during hemarthrosis approaches 100% and the natural evacuation time of blood from a joint is about 4 days, our results suggest that prompt evacuation of intraarticular blood or prevention of intraarticular bleeding might be crucial in preventing cartilage damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228136

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  24 in total

1.  The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy.

Authors:  Hillary J Braun; Hyeon Joo Kim; Constance R Chu; Jason L Dragoo
Journal:  Am J Sports Med       Date:  2014-03-14       Impact factor: 6.202

2.  A clinical feasibility study to evaluate the safety and efficacy of PEOT/PBT implants for human donor site filling during mosaicplasty.

Authors:  Lajos Bartha; Doreen Hamann; Jeroen Pieper; Fabiènne Péters; Jens Riesle; Andras Vajda; Pal Kaposi Novak; Laszlo Rudolf Hangody; Gabor Vasarhelyi; Laszlo Bodó; Clemens van Blitterswijk; Joost de Wijn; Annamaria Kenyeres; Laszlo Modis; Eszter Balo; Laszlo Hangody
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-12-06

3.  Blood exposure has a negative effect on engineered cartilage.

Authors:  C Sosio; F Boschetti; L Mangiavini; C Scotti; S Manzotti; M S Buragas; S Biressi; G Fraschini; A Gigante; G M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-10-28       Impact factor: 4.342

4.  Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Authors:  Aman Khurana; Fanny Chapelin; Graham Beck; Olga D Lenkov; Jessica Donig; Hossein Nejadnik; Solomon Messing; Nikita Derugin; Ray Chun-Fai Chan; Amitabh Gaur; Barbara Sennino; Donald M McDonald; Paul J Kempen; Grigory A Tikhomirov; Jianghong Rao; Heike E Daldrup-Link
Journal:  Radiology       Date:  2013-07-12       Impact factor: 11.105

5.  Ammonium-Chloride-Potassium Lysing Buffer Treatment of Fully Differentiated Cells Increases Cell Purity and Resulting Neotissue Functional Properties.

Authors:  Wendy E Brown; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Tissue Eng Part C Methods       Date:  2016-09       Impact factor: 3.056

6.  Quantitative versus semiquantitative MR imaging of cartilage in blood-induced arthritic ankles: preliminary findings.

Authors:  Andrea S Doria; Ningning Zhang; Bjorn Lundin; Pamela Hilliard; Carina Man; Ruth Weiss; Gary Detzler; Victor Blanchette; Rahim Moineddin; Felix Eckstein; Marshall S Sussman
Journal:  Pediatr Radiol       Date:  2014-02-13

7.  Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Authors:  Aman Khurana; Hossein Nejadnik; Fanny Chapelin; Olga Lenkov; Rakhee Gawande; Sungmin Lee; Sandeep N Gupta; Nooshin Aflakian; Nikita Derugin; Solomon Messing; Guiting Lin; Tom F Lue; Laura Pisani; Heike E Daldrup-Link
Journal:  Nanomedicine (Lond)       Date:  2013-03-27       Impact factor: 5.307

Review 8.  Advances and challenges in hemophilic arthropathy.

Authors:  Tine Wyseure; Laurent O Mosnier; Annette von Drygalski
Journal:  Semin Hematol       Date:  2015-10-26       Impact factor: 3.851

9.  Components in Plasma-Derived Factor VIII, But Not in Recombinant Factor VIII Downregulate Anti-Inflammatory Surface Marker CD163 in Human Macrophages through Release of CXCL4 (Platelet Factor 4).

Authors:  Anne Bertling; Martin F Brodde; Mayken Visser; Janina Treffon; Michelle Fennen; Anke C Fender; Reinhard Kelsch; Beate E Kehrel
Journal:  Transfus Med Hemother       Date:  2017-08-11       Impact factor: 3.747

Review 10.  Treatment strategies in children with hemophilia.

Authors:  Pia Petrini
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.